Head-To-Head Review: Cellectar Biosciences (NASDAQ:CLRB) versus Innovative Eyewear (NASDAQ:LUCY)

Cellectar Biosciences (NASDAQ:CLRB) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, analyst recommendations, risk and dividends.

Analyst Recommendations

This is a summary of current recommendations and price targets for Cellectar Biosciences and Innovative Eyewear, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cellectar Biosciences	1	0	3	0	2.50
Innovative Eyewear	1	1	0	0	1.50

Cellectar Biosciences currently has a consensus price target of $11.00, indicating a potential upside of 335.64%. Given Cellectar Biosciences’ stronger consensus rating and higher probable upside, equities analysts clearly believe Cellectar Biosciences is more favorable than Innovative Eyewear.

Valuation & Earnings

This table compares Cellectar Biosciences and Innovative Eyewear”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cellectar Biosciences	N/A	N/A	-$21.79 million	($6.66)	-0.38
Innovative Eyewear	$2.66 million	1.88	-$7.59 million	($1.69)	-0.46

Innovative Eyewear has higher revenue and earnings than Cellectar Biosciences. Innovative Eyewear is trading at a lower price-to-earnings ratio than Cellectar Biosciences, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Cellectar Biosciences and Innovative Eyewear’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cellectar Biosciences	N/A	-349.24%	-153.18%
Innovative Eyewear	-272.42%	-83.37%	-76.02%

Risk and Volatility

Cellectar Biosciences has a beta of 0.52, meaning that its stock price is 48% less volatile than the S&P 500. Comparatively, Innovative Eyewear has a beta of 2.66, meaning that its stock price is 166% more volatile than the S&P 500.

Insider & Institutional Ownership

16.4% of Cellectar Biosciences shares are held by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are held by institutional investors. 2.6% of Cellectar Biosciences shares are held by company insiders. Comparatively, 1.7% of Innovative Eyewear shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Cellectar Biosciences beats Innovative Eyewear on 7 of the 13 factors compared between the two stocks.

About Cellectar Biosciences

Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r head and neck cancer. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative with Orano Med to develop CLR 12120 Series; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.

About Innovative Eyewear

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.